Chris Murphy @ChrisMurphyCT
Trump shouldn't take the credit for the Pfizer/BioNTech progress, but it's not fair to suggest that this was simply a "private sector" effort. They got purchase/distribution contracts from the U.S., EU, and Japan, and BioNTech got $445M in funding from the German government. — PolitiTweet.org
Matthew Parent @MatthewParent1
Lots of people parsing words around this. Sure, Pfizer didn’t take open-ended R&D money. But a $2 billion guarantee… https://t.co/ssTwe…
